Medicare Enrolled
Dr. Mehran Movassaghi, M.D.
Urology Physician · Santa Monica, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Movassaghi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Movassaghi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Movassaghi
Dr. Mehran Movassaghi is an urology physician in Santa Monica, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Movassaghi performed 46,148 Medicare services across 2,550 unique beneficiaries.
Between the years covered by Open Payments, Dr. Movassaghi received a total of $58,246 from 55 pharmaceutical and/or device companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Movassaghi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 4% volume in CA
$58,246 industry payments
Medicare Practice Summary
Medicare Utilization ↗46,148
Medicare services
Top 4% in CA for urology physician
2,550
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,564 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
42,023 | $0 | $0 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
638 | $74 | $439 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
519 | $10 | $65 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
476 | $12 | $70 |
| Bladder emptying assessment A timed evaluation to measure how effectively the bladder empties urine. |
429 | $10 | $245 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
385 | $103 | $619 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
340 | $8 | $15 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
212 | $43 | $277 |
| Injection, garamycin, gentamicin, up to 80 mg | 172 | $2 | $13 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
119 | $138 | $864 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
97 | $89 | $542 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
89 | $220 | $1,226 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
84 | $91 | $556 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
77 | $127 | $720 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $128 | $801 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
46 | $50 | $310 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
38 | $102 | $755 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $103 | $609 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
31 | $69 | $384 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
31 | $66 | $387 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $66 | $371 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
29 | $633 | $4,774 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
29 | $102 | $558 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $73 | $439 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
20 | $282 | $1,645 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
20 | $284 | $1,601 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
17 | $76 | $740 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
16 | $47 | $275 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
15 | $60 | $354 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
14 | $95 | $519 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
14 | $3 | $16 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
13 | $294 | $1,947 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
94.1% medium
5.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$58,246
Total received (2018-2024)
Avg $8,321/year across 7 years
Top 5% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
373
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$45,934 (78.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,084 (20.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$228 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,855
2023
$24,724
2022
$2,466
2021
$1,370
2020
$1,095
2019
$1,106
2018
$1,629
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edap Technomed Inc
$22,767
AngioDynamics, Inc.
$1,184
HISTOSONICS,INC.
$439
Myriad Genetic Laboratories, Inc.
$225
PFIZER INC.
$173
Balt USA, LLC
$158
Noah Medical Corporation
$146
BIOTISSUE HOLDINGS INC.
$127
Blue Earth Diagnostics Limited
$119
ABBVIE INC.
$115
Medtronic, Inc.
$66
PROGENICS PHARMACEUTICALS, INC.
$55
Endo Pharmaceuticals Inc.
$42
Novartis Pharmaceuticals Corporation
$32
KOELIS Inc.
$31
PROCEPT BioRobotics Corporation
$29
180 Medical, Inc.
$26
Teleflex LLC
$25
Hologic Sales and Service, LLC
$25
Astellas Pharma US Inc
$22
Ferring Pharmaceuticals Inc.
$19
UROGEN PHARMA, INC.
$17
Tolmar, Inc.
$14
Top 3 companies account for 94.3% of 2024 payments
All-time payments by company (2018-2024) ›
Edap Technomed Inc
$22,767
EDAP TECHNOMED INC
$22,314
Endo Pharmaceuticals Inc.
$1,841
PROCEPT BioRobotics Corporation
$1,757
Myriad Genetic Laboratories, Inc.
$1,737
AngioDynamics, Inc.
$1,511
PFIZER INC.
$844
Amgen Inc.
$503
HISTOSONICS,INC.
$439
Antares Pharma, Inc.
$412
Coloplast Corp
$295
Teleflex LLC
$290
BIOTISSUE HOLDINGS, INC.
$251
Astellas Pharma US Inc
$250
Olympus America Inc.
$227
ABBVIE INC.
$221
Allergan, Inc.
$214
TOLMAR Pharmaceuticals, Inc.
$171
Balt USA, LLC
$158
Blue Earth Diagnostics Limited
$150
Noah Medical Corporation
$146
BIOTISSUE HOLDINGS INC.
$127
Allergan Inc.
$114
Boston Scientific Corporation
$111
Acerus Pharmaceuticals Corporation
$101
NeoTract Inc.
$97
Progenics Pharmaceuticals, Inc.
$90
Supernus Pharmaceuticals, Inc.
$88
180 Medical, Inc.
$83
Dendreon Pharmaceuticals LLC
$69
Medtronic, Inc.
$66
COLOPLAST CORP
$61
PROGENICS PHARMACEUTICALS, INC.
$55
Merck Sharp & Dohme Corporation
$53
Sumitomo Pharma America, Inc.
$50
Medtronic USA, Inc.
$45
UroGen Pharma, Inc.
$45
Bayer HealthCare Pharmaceuticals Inc.
$44
Metuchen Pharmaceuticals
$41
Avadel Specialty Pharmaceuticals, LLC
$39
Tolmar, Inc.
$35
Cook Medical LLC
$33
Novartis Pharmaceuticals Corporation
$32
Axonics Modulation Technologies, Inc.
$32
KOELIS Inc.
$31
Retrophin, Inc.
$25
Hologic Sales and Service, LLC
$25
AbbVie Inc.
$24
Kowa Pharmaceuticals America, Inc.
$21
AstraZeneca Pharmaceuticals LP
$20
ABC Home Medical Supply, Inc.
$19
Ferring Pharmaceuticals Inc.
$19
BioTissue Holdings, Inc.
$17
UROGEN PHARMA, INC.
$17
KARL STORZ Endoscopy-America
$16
Top 3 companies account for 80.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · APTIMA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AquaBeam Robotic System · Axonics r-SNM System · Axumin · BOTOX · BRACANALYSIS CDX · BRACAnalysis CDx · CONTINENCE CARE · COOK MEDICAL UROLOGY · Cook Medical Urology · ELIGARD · EVENITY · GALAXY · GEMTESA · GENERAL BPH · GENERAL BPH · GENTLECATH · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · MYRBETRIQ · MYRISK · NANOKNIFE · NEOX · NOCDURNA · NanoKnife · Natesto · Noctiva · Nubeqa · OTREXUP · Otrexup · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prestige Coil System · Prolaris · Prolia · SEGLENTIS · SPEEDICATH · SpeediCath · Stendra · TOVIAZ · Titan · Trinity · UROLIFT · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · iTIND System · n.a. · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for urology physician in CA.
Geographic Context
Urology physicians within 10 mi
349
Per 100K population
3.5
County median income
$87,760
Nearest hospital
SANTA MONICA - UCLA MED CTR & ORTHOPAEDIC HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Movassaghi is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with consulting-driven industry engagement in the top 5% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Movassaghi experienced with testosterone injection?
Based on Medicare claims data, Dr. Movassaghi performed 42,023 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Movassaghi receive payments from pharmaceutical companies?
Yes. Dr. Movassaghi received a total of $58,246 from 55 companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Movassaghi's costs compare to other urology physicians in Santa Monica?
Dr. Movassaghi's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Movassaghi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Santa Monica
Browse urology physicians in Santa Monica ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Edap Technomed Inc Payments to Doctors
See all physicians who received payments from Edap Technomed Inc.
By company
EDAP TECHNOMED INC Payments to Doctors
See all physicians who received payments from EDAP TECHNOMED INC.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology